Automated Insulin Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244594

Publication Date:

November 12, 2024

Pages:

118

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The Automated Insulin Delivery Device is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Automated Insulin Delivery Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an Automated Insulin Delivery System is referred to as a "closed-loop" system, an "Artificial pancreas" system, or an "autonomous system for glycemic control."

An Automated Insulin Delivery System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global market for Automated Insulin Delivery Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Automated Insulin Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Automated Insulin Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Automated Insulin Delivery Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Automated Insulin Delivery Device include Medtronic, Dexcom, Abbott, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, Beta Bionics, Admetsys and Defymed, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automated Insulin Delivery Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automated Insulin Delivery Device by region & country, by Type, and by Application.
The Automated Insulin Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Insulin Delivery Device.
Market Segmentation
By Company
Medtronic
Dexcom
Abbott
Insulet
Tandem Diabetes Care
Bigfoot Biomedical
Beta Bionics
Admetsys
Defymed
Micro Tech Medical
Segment by Type:
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospital
Clinic
Medical Research Center
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automated Insulin Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Automated Insulin Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Automated Insulin Delivery Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Automated Insulin Delivery Device Product Introduction
1.2 Global Automated Insulin Delivery Device Market Size Forecast
1.2.1 Global Automated Insulin Delivery Device Sales Value (2019-2030)
1.2.2 Global Automated Insulin Delivery Device Sales Volume (2019-2030)
1.2.3 Global Automated Insulin Delivery Device Sales Price (2019-2030)
1.3 Automated Insulin Delivery Device Market Trends & Drivers
1.3.1 Automated Insulin Delivery Device Industry Trends
1.3.2 Automated Insulin Delivery Device Market Drivers & Opportunity
1.3.3 Automated Insulin Delivery Device Market Challenges
1.3.4 Automated Insulin Delivery Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Automated Insulin Delivery Device Players Revenue Ranking (2023)
2.2 Global Automated Insulin Delivery Device Revenue by Company (2019-2024)
2.3 Global Automated Insulin Delivery Device Players Sales Volume Ranking (2023)
2.4 Global Automated Insulin Delivery Device Sales Volume by Company Players (2019-2024)
2.5 Global Automated Insulin Delivery Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Automated Insulin Delivery Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Automated Insulin Delivery Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Automated Insulin Delivery Device
2.9 Automated Insulin Delivery Device Market Competitive Analysis
2.9.1 Automated Insulin Delivery Device Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Automated Insulin Delivery Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automated Insulin Delivery Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Threshold Suspended Device Systems
3.1.2 Hybrid Closed-loop APDS
3.1.3 Other Systems
3.2 Global Automated Insulin Delivery Device Sales Value by Type
3.2.1 Global Automated Insulin Delivery Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Automated Insulin Delivery Device Sales Value, by Type (2019-2030)
3.2.3 Global Automated Insulin Delivery Device Sales Value, by Type (%) (2019-2030)
3.3 Global Automated Insulin Delivery Device Sales Volume by Type
3.3.1 Global Automated Insulin Delivery Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Automated Insulin Delivery Device Sales Volume, by Type (2019-2030)
3.3.3 Global Automated Insulin Delivery Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Automated Insulin Delivery Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Medical Research Center
4.2 Global Automated Insulin Delivery Device Sales Value by Application
4.2.1 Global Automated Insulin Delivery Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Automated Insulin Delivery Device Sales Value, by Application (2019-2030)
4.2.3 Global Automated Insulin Delivery Device Sales Value, by Application (%) (2019-2030)
4.3 Global Automated Insulin Delivery Device Sales Volume by Application
4.3.1 Global Automated Insulin Delivery Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Automated Insulin Delivery Device Sales Volume, by Application (2019-2030)
4.3.3 Global Automated Insulin Delivery Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Automated Insulin Delivery Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Automated Insulin Delivery Device Sales Value by Region
5.1.1 Global Automated Insulin Delivery Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Automated Insulin Delivery Device Sales Value by Region (2019-2024)
5.1.3 Global Automated Insulin Delivery Device Sales Value by Region (2025-2030)
5.1.4 Global Automated Insulin Delivery Device Sales Value by Region (%), (2019-2030)
5.2 Global Automated Insulin Delivery Device Sales Volume by Region
5.2.1 Global Automated Insulin Delivery Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Automated Insulin Delivery Device Sales Volume by Region (2019-2024)
5.2.3 Global Automated Insulin Delivery Device Sales Volume by Region (2025-2030)
5.2.4 Global Automated Insulin Delivery Device Sales Volume by Region (%), (2019-2030)
5.3 Global Automated Insulin Delivery Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Automated Insulin Delivery Device Sales Value, 2019-2030
5.4.2 North America Automated Insulin Delivery Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Automated Insulin Delivery Device Sales Value, 2019-2030
5.5.2 Europe Automated Insulin Delivery Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Automated Insulin Delivery Device Sales Value, 2019-2030
5.6.2 Asia Pacific Automated Insulin Delivery Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Automated Insulin Delivery Device Sales Value, 2019-2030
5.7.2 South America Automated Insulin Delivery Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Automated Insulin Delivery Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Automated Insulin Delivery Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Automated Insulin Delivery Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Automated Insulin Delivery Device Sales Value
6.2.1 Key Countries/Regions Automated Insulin Delivery Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Automated Insulin Delivery Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Automated Insulin Delivery Device Sales Value, 2019-2030
6.3.2 United States Automated Insulin Delivery Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Automated Insulin Delivery Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Automated Insulin Delivery Device Sales Value, 2019-2030
6.4.2 Europe Automated Insulin Delivery Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Automated Insulin Delivery Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Automated Insulin Delivery Device Sales Value, 2019-2030
6.5.2 China Automated Insulin Delivery Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Automated Insulin Delivery Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Automated Insulin Delivery Device Sales Value, 2019-2030
6.6.2 Japan Automated Insulin Delivery Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Automated Insulin Delivery Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Automated Insulin Delivery Device Sales Value, 2019-2030
6.7.2 South Korea Automated Insulin Delivery Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Automated Insulin Delivery Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Automated Insulin Delivery Device Sales Value, 2019-2030
6.8.2 Southeast Asia Automated Insulin Delivery Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Automated Insulin Delivery Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Automated Insulin Delivery Device Sales Value, 2019-2030
6.9.2 India Automated Insulin Delivery Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Automated Insulin Delivery Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Automated Insulin Delivery Device Product Offerings
7.1.5 Medtronic Recent Development
7.2 Dexcom
7.2.1 Dexcom Company Information
7.2.2 Dexcom Introduction and Business Overview
7.2.3 Dexcom Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Dexcom Automated Insulin Delivery Device Product Offerings
7.2.5 Dexcom Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Automated Insulin Delivery Device Product Offerings
7.3.5 Abbott Recent Development
7.4 Insulet
7.4.1 Insulet Company Information
7.4.2 Insulet Introduction and Business Overview
7.4.3 Insulet Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Insulet Automated Insulin Delivery Device Product Offerings
7.4.5 Insulet Recent Development
7.5 Tandem Diabetes Care
7.5.1 Tandem Diabetes Care Company Information
7.5.2 Tandem Diabetes Care Introduction and Business Overview
7.5.3 Tandem Diabetes Care Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Tandem Diabetes Care Automated Insulin Delivery Device Product Offerings
7.5.5 Tandem Diabetes Care Recent Development
7.6 Bigfoot Biomedical
7.6.1 Bigfoot Biomedical Company Information
7.6.2 Bigfoot Biomedical Introduction and Business Overview
7.6.3 Bigfoot Biomedical Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bigfoot Biomedical Automated Insulin Delivery Device Product Offerings
7.6.5 Bigfoot Biomedical Recent Development
7.7 Beta Bionics
7.7.1 Beta Bionics Company Information
7.7.2 Beta Bionics Introduction and Business Overview
7.7.3 Beta Bionics Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Beta Bionics Automated Insulin Delivery Device Product Offerings
7.7.5 Beta Bionics Recent Development
7.8 Admetsys
7.8.1 Admetsys Company Information
7.8.2 Admetsys Introduction and Business Overview
7.8.3 Admetsys Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Admetsys Automated Insulin Delivery Device Product Offerings
7.8.5 Admetsys Recent Development
7.9 Defymed
7.9.1 Defymed Company Information
7.9.2 Defymed Introduction and Business Overview
7.9.3 Defymed Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Defymed Automated Insulin Delivery Device Product Offerings
7.9.5 Defymed Recent Development
7.10 Micro Tech Medical
7.10.1 Micro Tech Medical Company Information
7.10.2 Micro Tech Medical Introduction and Business Overview
7.10.3 Micro Tech Medical Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Micro Tech Medical Automated Insulin Delivery Device Product Offerings
7.10.5 Micro Tech Medical Recent Development
8 Industry Chain Analysis
8.1 Automated Insulin Delivery Device Industrial Chain
8.2 Automated Insulin Delivery Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Automated Insulin Delivery Device Sales Model
8.5.2 Sales Channel
8.5.3 Automated Insulin Delivery Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Medtronic
Dexcom
Abbott
Insulet
Tandem Diabetes Care
Bigfoot Biomedical
Beta Bionics
Admetsys
Defymed
Micro Tech Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂